Skip to content

T · 8113.T · HOUSEHOLD & PERSONAL PRODUCTS

Unicharm Corporation (8113.T) intrinsic value and stock valuation

$1,085.50as of 2026-11-21 · Mkt cap 1.64T

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Unicharm Corporation DCF and intrinsic value

InvestorsCraft values 8113.T with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from 8113.T’s statements →

Unicharm Corporation Graham Number

Graham Number: $654.17d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Consumer Defensive · Household & Personal Products Tokyo unicharm.co.jp

How the business is doing

Fiscal 2011–2025, USD

Revenue
$945.3B+5.4% 5y CAGRd
20112025
Net income
$65.2B+4.5% 5y CAGRd
20112025
Free cash flow
$102.8B-2.2% 5y CAGRd
20112025
Total equity
$891.3B+9.6% 5y CAGRd
20112025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Financials

Statements by fiscal year

Fiscal 2011–2025, USD
20252024202320222021
Revenue$945.3B$989B$941.8B$898B$782.7B
Operating income$108.9B$138.5B$128B$119.6B$122.5B
Net income$65.2B$81.8B$86.1B$67.6B$72.7B
EPSd$37.3M$46.4M$48.5M$37.9M$40.6M
Operating cash flow$131.5B$137.1B$162.4B$92.2B$105.3B
Capital expenditure-$-28.63B-$-39.33B-$-38.41B-$-32.95B-$-34.67B
Free cash flow$102.8B$97.8B$124B$59.3B$70.6B
Total assets$1.22T$1.24T$1.13T$1.05T$987.7B
Total debt$11.1B$61.8B$61.3B$57.1B$75.5B
Net debt-$-242.04B-$-199.23B-$-192.43B-$-160.03B-$-112.08B
Total equity$891.3B$873.7B$788.3B$708.6B$635.4B
Cash and short-term investments$253.1B$353.9B$334.4B$293B$293.1B
Income statement
20252024202320222021
Revenue$945.3B$989B$941.8B$898B$782.7B
Cost of revenue$589.4B$612.6B$601.4B$579.8B$479.6B
Gross profit$355.9B$376.4B$340.4B$318.2B$303.1B
Research and development expenses$13.6B$10.3B$9.82B$8.27B$8.18B
Selling, general and administrative expenses$233.4B$227.6B$202.6B$190.4B$172.4B
Other expenses$0.00$0.00$0.00$0.00$0.00
Operating expenses$247B$237.9B$212.4B$198.7B$180.6B
Cost and expenses$836.4B$850.5B$813.8B$778.5B$660.2B
Interest income$7.34B$8.77B$5.76B$3.8B$3.02B
Interest expense$3.93B$3.24B$3.51B$2.8B$1.51B
Depreciation and amortization$47.8B$46.5B$43.3B$41.5B$37.9B
Ebitda$156.7B$185B$171.2B$161.1B$160.4B
Operating income$108.9B$138.5B$128B$119.6B$122.5B
Total other income/expenses, net-$-3.5B-$-3.93B$4.33B-$-3.86B-$-506M
Income before tax$105.4B$134.5B$132.3B$115.7B$122B
Income tax expense$34.5B$39.3B$34.3B$37.3B$38.4B
Net income$65.2B$81.8B$86.1B$67.6B$72.7B
Weighted average shares outstanding$1.75B$1.76B$1.78B$1.79B$1.79B
Weighted average diluted shares outstanding$1.75B$1.76B$1.78B$1.79B$1.79B
Balance sheet
20252024202320222021
Cash and short-term investments$253.1B$353.9B$334.4B$293B$293.1B
Net receivables$154.8B$168.6B$151.6B$153B$129.4B
Inventory$123.3B$121.1B$103B$117.6B$89.8B
Total current assets$641.6B$671B$638.9B$603.8B$547.7B
Property, plant and equipment, net$275.7B$293.2B$285.6B$271.7B$271.7B
Goodwill and intangible assets$97.1B$101.1B$95.7B$90.5B$85.4B
Long-term investments$180.2B$136.2B$90.7B$66.4B$66.8B
Total non-current assets$581.5B$568.9B$494.7B$445.5B$439.9B
Total assets$1.22T$1.24T$1.13T$1.05T$987.7B
Accounts payable$221.6B$131.3B$125.2B$127.9B$121.5B
Short-term debt$3.49B$27.7B$20.9B$17.1B$39.3B
Deferred revenue$0.00$0.00$0.00$0.00$0.00
Total current liabilities$263.9B$301.6B$270.1B$256.7B$274.5B
Long-term debt$7.57B$34.1B$40.4B$40.1B$36.2B
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$68B$64.7B$75.3B$83.9B$77.8B
Capital lease obligations$0.00$28.3B$26.8B$23.8B$31.8B
Total liabilities$331.9B$366.3B$345.4B$340.6B$352.2B
Common stock$16B$16B$16B$16B$16B
Retained earnings$801.4B$766.3B$710.8B$644.9B$599.9B
Accumulated other comprehensive income (loss)$106.2B$98.7B$59.2B$26.5B-$-4.45B
Total equity$891.3B$873.7B$788.3B$708.6B$635.4B
Total investments$180.2B$229.1B$171.3B$142.2B$172.3B
Total debt$11.1B$61.8B$61.3B$57.1B$75.5B
Net debt-$-242.04B-$-199.23B-$-192.43B-$-160.03B-$-112.08B
Cash flow statement
20252024202320222021
Net income$65.2B$81.8B$86.1B$67.6B$72.7B
Depreciation and amortization$47.8B$46.5B$43.3B$41.5B$37.9B
Stock-based compensation$0.00$0.00$0.00$0.00$0.00
Change in working capital$13.2B-$-565M$22.3B-$-35.93B-$-24.41B
Accounts receivable$13.6B-$-9.38B$8.27B-$-22.91B-$-4.72B
Inventory-$-1.92B-$-12.13B$20.7B-$-22.47B-$-23.15B
Accounts payable-$-8.67B$15.7B-$-12.33B-$-1.27B$14.2B
Net cash provided by operating activities$131.5B$137.1B$162.4B$92.2B$105.3B
Investments in property, plant and equipment-$-28.63B-$-39.33B-$-38.41B-$-32.95B-$-34.67B
Acquisitions, net$2.13B$76M-$-10.23B$2.91B$664M
Net cash used for investing activities-$-55.94B-$-73.84B-$-67.45B-$-4.28B-$-79.84B
Common stock issued$0.00$0.00$0.00$1.91B$1.9B
Common stock repurchased-$-22B-$-19B-$-17B-$-17B-$-16B
Dividends paid-$-28.65B-$-24.7B-$-23.1B-$-22.05B-$-20.3B
Net cash used for financing activities-$-86.64B-$-66.79B-$-67.09B-$-64.52B-$-45.18B
Net change in cash-$-7.96B$7.28B$36.6B$29.6B-$-11.98B
Cash at end of period$253.1B$261.1B$253.8B$217.2B$187.5B
Operating cash flow$131.5B$137.1B$162.4B$92.2B$105.3B
Capital expenditure-$-28.63B-$-39.33B-$-38.41B-$-32.95B-$-34.67B
Free cash flow$102.8B$97.8B$124B$59.3B$70.6B
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Unicharm Corporation

        Unicharm Corporation engages in the manufacture and sale of baby and childcare, feminine care, health care, cosmetic, household, and pet care products in Japan and internationally. Its baby and child care products, including disposable diapers and baby wipes under the Moony, MamyPoko, Oyasumiman, and Torepanman brands; and feminine care products comprise napkins, tampons, panty liners, sanitary short, and other feminine care products under the Sofy, Center-In, and Unicharm brands. The company's wellness care products include napkin-type incontinence pads, pants-type diapers, tape-type diapers, pants-type specialized urine pads, and tape-type specialized urine pads under the Lifree and Charmnap brand; and masks under the Unicharm brands. It also provides home care products, including cleaning sheets under the Wave brand; cosmetic cotton and wet wipes under the Silcot brand; and paper towels under the Cook Up brand. In addition, the company offers pet care products that include pet foods, excrement cleanup sheets, system toilets, and disposable diapers under the Grand Deli, Best Balance, Physicalife Dog, Silver Plate, Manner Wear, Deo Sheet, Silver Spoon, AllWell, Physicalife Cat, Deo Toilet, Deo Sand, Deo Clean, Aiken Genki, and Neko Genki brands. Further, it is involved in the manufacture and sale of industrial materials, food-packaging materials, etc. The company was incorporated in 1941 and is headquartered in Tokyo, Japan.

        CEO
        Takahisa Takahara
        Employees
        1.4K
        Beta
        0.25

        Included in

        Explore

        Frequently asked questions

        What is the intrinsic value of Unicharm Corporation (8113.T)?

        InvestorsCraft does not currently publish an intrinsic value for 8113.T. How the IC value is calculated.

        Is 8113.T undervalued?

        InvestorsCraft does not publish an undervaluation signal for 8113.T at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.